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The Aging Process of the Heart:
Obesity Is the Main Risk Factor for
Left Atrial Enlargement During Aging
The MONICA/KORA (Monitoring of Trends
and Determinations in Cardiovascular Disease/
Cooperative Research in the Region of Augsburg) Study
Jan Stritzke, MD,* Marcello Ricardo Paulista Markus, MD,*†‡ Stefanie Duderstadt, MD,*
Wolfgang Lieb, MD,* Andreas Luchner, MD,§ Angela Döring, MD, Ulrich Keil, MD,‡
Hans-Werner Hense, MD,‡ Heribert Schunkert, MD,* for the MONICA/KORA Investigators
Lübeck, Münster, Regensburg, and Neuherberg, Germany; and São Paulo, Brazil
Objectives This prospective study evaluated the association of obesity and hypertension with left atrial (LA) volume
over 10 years.
Background Although left atrial enlargement (LAE) is an independent risk factor for atrial fibrillation, stroke, and death, little
information is available about determinants of LA size in the general population.
Methods Participants (1,212 men and women, age 25 to 74 years) originated from a sex- and age-stratified random sam-
ple of German residents of the Augsburg area (MONICA S3). Left atrial volume was determined by standardized
echocardiography at baseline and again after 10 years. Left atrial volume was indexed to body height (iLA). Left
atrial enlargement was defined as iLA 35.7 and 33.7 ml/m in men and women, respectively.
Results At baseline, the prevalence of LAE was 9.8%. Both obesity and hypertension were independent predictors of LAE,
obesity (odds ratio [OR]: 2.4; p  0.001) being numerically stronger than hypertension (OR: 2.2; p  0.001).
Adjusted mean values for iLA were significantly lower in normal-weight hypertensive patients (25.4 ml/m) than
in obese normotensive individuals (27.3 ml/m; p  0.016). The highest iLA was found in the obese hypertensive
subgroup (30.0 ml/m; p  0.001 vs. all other groups). This group also presented with the highest increase in iLA
(6.0 ml/m) and the highest incidence (31.6%) of LAE upon follow-up.
Conclusions In the general population, obesity appears to be the most important risk factor for LAE. Given the increasing
prevalence of obesity, early interventions, especially in young obese individuals, are essential to prevent prema-
ture onset of cardiac remodeling at the atrial level. (J Am Coll Cardiol 2009;54:1982–9) © 2009 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.07.034v
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Ct an individual level, the combination of excessive caloric
ntake, lack of physical activity, and genetic susceptibility
as resulted in a dramatic increase in the prevalence of
besity worldwide (1,2).
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November 17, 2009:1982–9 Risk Factors for Left Atrial Enlargementith an increased LV mass with the pattern of eccentric
ypertrophy. Essential hypertension, by contrast, results
ost frequently in a concentric increase of LV mass.
ccentric and concentric hypertrophy both impair ventric-
lar filling and thus facilitate the development of diastolic
ysfunction (8), ultimately leading to left atrial enlargement
LAE) (9). In fact, LAE is known as a sensitive indicator of
V pre-load (10). Chronic volume overload related to
besity or chronic pressure overload related to hypertension
ay therefore both result in LAE.
Hemodynamically, the left atrium has 3 major functions.
t serves as: 1) a reservoir that collects pulmonary venous
eturn during ventricular systole; 2) a conduit for the passage
f blood from the left atrium to the left ventricle during
arly ventricular diastole; and 3) a contractile pump that
nhances LV filling in late diastole (11). Consequently, LV
lling and performance may also be influenced by LAE.
This study evaluated the aforementioned association
etween obesity and arterial hypertension with LAE. In the
rst step, we investigated the association of different car-
iovascular risk factors with LA size. In the second step, we
elineated the influence of obesity and hypertension on LA
ize and the prevalence of LAE. Finally, we evaluated the
ffects of obesity and arterial hypertension on changes of LA
olume during 10 years of follow-up and incidental devel-
pment of LAE in a well-characterized population-based
ample.
ethods
tudy sample. Between October 1994 and June 1995,
aseline data were obtained from the third survey (S3) of the
opulation-based MONICA (Monitoring of Trends and
eterminations in Cardiovascular Disease) & Augsburg/
ORA (Cooperative Research in the Region of Augsburg)
tudy. Only participants age 25 to 74 years at baseline who
isplayed echocardiographic M-mode tracings with suffi-
ient quality for quantitative measurements at baseline were
lso eligible for an echocardiographic investigation at
ollow-up (F3) that was conducted between March 2004
nd May 2005. The MONICA Augsburg project was part
f the international collaborative World Health Organiza-
ion MONICA project (12) and investigated the cardiovas-
ular risk factor profile of randomly selected subjects of the
esident population in cross-sectional surveys (13). The
tudy design, sampling frame, and data collection have been
escribed in detail elsewhere (12,13).
From a total of 1,675 participants in S3, 1,417 displayed
ufficient echocardiographic M-mode tracings. However, a
umber of these participants were inaccessible or ineligible
or the F3 follow-up examination because of death (58),
nterdiction of re-contact (63), migration (41), or severe
llness (7). From the remaining 1,248 individuals who were
nvited to the re-examination, 1,005 participated in the
ollow-up study (net response 80.5%). For these particular
nalyses only, data derived from individuals with adequate echocardiographic images of the
-chamber view were used (S3
,212 individuals; F3  914 in-
ividuals). Compared with the
ntire sample, these individuals
ere significantly younger and
resented with lower body mass
ndex (BMI) and systolic blood
ressure levels.
nterview and medical exami-
ation. On both occasions, all
articipants underwent an inter-
iew related to personal medical
istory, lifestyle, and health behavior. Obesity was defined
ccording to the National Institutes of Health Consensus
evelopment Panel criteria (14) as BMI 27.3 kg/m2 in
en and 27.8 kg/m2 in women. Resting blood pressure
as measured under strictly standardized conditions. Arte-
ial hypertension was considered at a systolic blood pressure
140 mm Hg and/or a diastolic blood pressure 90 mm
g or current intake of antihypertensive medication. In
ddition, participants underwent standardized medical ex-
minations including collection of a nonfasting venous
lood sample. Diabetes mellitus was defined by the patient’s
elf-report. Hypercholesterolemia was defined as a low-
ensity lipoprotein cholesterol level 130 mg/dl. Cardio-
ascular disease was defined as stroke or myocardial infarc-
ion reported by standard questionnaire.
chocardiography. Echocardiograms were performed us-
ng commercially available echocardiographs (in S3 Sonos
500 and in F3 Sonos 4500, Philips Electronics, Eind-
oven, the Netherlands). To reduce interobserver variabil-
ty, all tracings were analyzed by a single cardiologist at each
xamination. Echocardiographic measurements were cor-
ected for observer- and device-related differences between
he 2 examinations. All echocardiographic investigations
nd reading procedures were performed following a stan-
ardized protocol. The quality of the echocardiographic
nvestigations was assessed as previously described by the
HIP (Study of Health in Pomerania) study group (15).
ssessment of LA volume. Measurements of the LA
olume were performed at end-systole of the left ventricle in
he apical 4-chamber view by planimetry (Fig. 1). As
uperior border of the atrial outline, a straight line connect-
ng both sides of mitral valve attachment points to the valve
ing was taken. Both the atrial appendage and the pulmo-
ary veins, when visualized, were carefully excluded (16).
eft atrial volume was then calculated using the methods of
iscs (the Simpson rule).
ssessment of LA pressure and volume load. Pulmonary
enous flows were used to assess mean LA pressure (17).
ulmonary vein Doppler was obtained by placing a color
ow-guided 3- to 4-mm sample volume 1- to 3-cm deep
ithin the pulmonary vein. Left atrial pressure load was
Abbreviations
and Acronyms
BMI  body mass index
BSA  body surface area
iLA  indexed left atrial
volume
LA  left atrial
LAE  left atrial
enlargement
LV  left ventricular
SV  stroke volumestimated by calculation of S/D ratio.
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Risk Factors for Left Atrial Enlargement November 17, 2009:1982–9Because all individuals with significant valvular disease were
xcluded, LV stroke volume (SV) should be equal to LA
olume load. Left ventricular SV (ml) was calculated as:
VTILVOT  (0.5  LVOT)
2  
18) where VTI represents the velocity time integral, and
VOT represents LV outflow tract. Both parameters were
nly available for the F3 follow-up study.
tatistical analysis. Blood pressure measurements and
chocardiography had to be carried out with different
ethods in S3 and F3 because observers had changed after
0 years and the devices had been replaced, reflecting
echnologic progress. Systematic differences between sur-
eys owing to different measurement methods were assessed
y using data from all 1,005 individuals examined on both
ccasions using a mixed regression model. We specified a
inear model with an individual random intercept for each
articipant. The variance of this intercept and thus the
orrelation between the 2 measurements of each individual
ere assumed to be equal for all participants. The model
lso included age, sex, BMI, and antihypertensive medica-
ion as covariates. An interaction term between sex and
tudy was included to allow for statistically significant effects
f measurement devices in men and women. Systematic
ifferences estimated from these models were used to derive
orrection values that were applied to all values recorded in
he baseline survey of 1994 to 1995.
To assess the relations between indexed left atrial volume
iLA) (dependent variable) and age, sex, cardiovascular
Figure 1 Measurements of Left Atrial Volume
Measurements were performed at end systole in the apical 4-chamber view by
planimetry. As the superior border of the atrial outline, a straight line connect-
ing both sides of the mitral valve attachment points to the valve ring was
taken. Both the atrial appendage and the pulmonary veins, when visualized,
were carefully excluded. Left atrial volume was calculated using the methods of
discs (the Simpson rule).isease, and cardiovascular risk factors, age, sex, S/D ratio,
d
ind SV standardized regression coefficients () and respec-
ive p values were calculated using linear regression models.
Because there are no generally accepted reference values
ublished to define LAE based on iLA, partition values
derived as mean value  2 SDs) were generated within a
ealthy reference group excluding all participants with
vidence of mitral regurgitation, hypertension, obesity, di-
betes, or cardiovascular disease. Prevalence and incidence
dds ratios (ORs) for LAE were calculated using a logistic
egression model with arterial hypertension and obesity as
he predictors of interest adjusted for age and sex. To
stimate the relative impact of predictors on LAE, we
alculated the population-attributable risk percent (19).
opulation-attributable risk percent expresses the propor-
ion of LAE in the study population that is attributable to
he exposure of predisposing factors and that theoretically
ould be eliminated if the exposure was eliminated. It was
alculated using the formula:
PAR%  (Pe[POR 1] ⁄ [Pe(POR 1)  1])  100
here PAR% indicates the population-attributable risk
ercent, Pe represents the proportion of the population
xposed to the risk factor, and POR indicates the adjusted
revalence OR. Finally, adjusted means for iLA and for
bsolute changes of iLA comparing baseline and follow-up
easurements were estimated for groups with single or
oncurrent presence of hypertension and obesity using
nalyses of variance adjusted for age and sex. All analyses
haracteristics of the Total Study Samplend Healthy Reference GroupTable 1 Charact ristics of the Total Study Sampleand Healthy Reference Group
Healthy Reference Group
(n  433)
Total Study Sample
(n  1,212)
Age (yrs) 42.1 11.4 48.5 13.7
Male sex 40.2 48.0
BMI (kg/m2) 23.8 2.3 26.2 3.9
SBP (mm Hg) 114 12 125 19
DBP (mm Hg) 75 8 81 11
Obese — 34.2
Hypertensive — 36.4
Current smoker 28.9 28.1
Hypercholesterolemia 68.7 76.7
Atrial fibrillation — 0.8
Cardiovascular disease — 1.2
Diabetes mellitus — 2.1
LV mass (g) 137 35 160 48
e/a ratio 1.51 0.53 1.28 0.50
LA (M-mode) (mm) 34 4 37 5
LA volume (ml) 39 10 43 14
LA volume/BSA (ml/m2) 22 5 23 7
LA volume/height (ml/m) 23 6 26 8
alues are mean  SD or %.
BMI  body mass index; BSA  body surface area; DBP  diastolic blood pressure; e/a ratio 
atio of early to late transmitral flow velocities; LA  left atrial; LA (M-mode)  anteroposterior
iameter of left atrium in parasternal long axis view; LA volume  volume of left atrium obtained
n apical 4-chamber view; LV  left ventricular; SBP  systolic blood pressure.
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November 17, 2009:1982–9 Risk Factors for Left Atrial Enlargementere performed using SPSS version 17.0 for Windows
SPSS Inc., Chicago, Illinois).
esults
elation of cardiovascular risk factors to LA volume. Clini-
al characteristics and echocardiographic parameters of the
ntire study sample and a healthy subgroup are shown in Table 1.
s compared with the entire sample, the healthy reference
roup was substantially younger and presented with lower
ystolic and diastolic blood pressure levels, better diastolic
unction (as indicated by a higher e/a ratio), lower average
alues for BMI and LV mass, and smaller LA size.
Left atrial volume was normalized to body height (iLA) in
he remainder of the study because such indexing results in
etter discrimination of the effects related to obesity (20,21).
To evaluate the influence of different cardiovascular risk
actors on LA size, several linear regression analyses were
erformed (Table 2). Strong associations with LA size were
bserved for obesity, arterial hypertension, and age. When
he standardized regression coefficients () were compared,
he effect of obesity was almost twice the effect of hyper-
ension. Of note, when the relation of cardiovascular risk
actors to absolute changes of iLA volume during 10 years of
ollow-up was analyzed (Table 2, model 3), there was no
ignificant effect of hypertension detectable. Similar results
ere found after replacing categoric variables by their
ontinuous counterparts (e.g., replacing arterial hyperten-
ion [y/n] by systolic blood pressure [mm Hg]; data not
hown). In this particular study, no association of LA size
ith diabetes and hypercholesterolemia was observed. A
protective effect” of smoking was likely caused by colinear-
ty to age owing to the high number of young smokers.
revalence of LAE. Partition values for the definition of
AE were calculated within a healthy reference group
Table 3). Left atrial enlargement was defined as iLA35.7
l/m in men and 33.7 ml/m in women.
The crude prevalence of LAE in the total study sample
as 9.6% for men and 10.0% for women (p  0.825 for the
ifference between the sexes). In the normal-weight normo-
elation of Cardiovascular Risk Factors to iLATable 2 Relation of Cardiovascular Risk Factors to iLA
Model 1 iLA
Dependent Variable  p Value
Age (yrs) 0.085 0.026
Female sex 0.040 0.234
Obesity (y/n) 0.222 0.001
Hypertension (y/n) 0.121 0.001
Current smoker (y/n) 0.088 0.009
Hypercholesterolemia (y/n) 0.028 0.424
Diabetes mellitus (y/n) 0.001 0.965
Cardiovascular disease (y/n) 0.056 0.086
elation of cardiovascular risk factors to iLA (models 1 and 2) at baseline investigation and iLA (
odels including age, sex, cardiovascular disease, and all cardiovascular risk factors (model 1; R2
2besity, hypertension, cardiovascular disease, and the baseline measurement of iLA (model 3; R  0.09
iLA  indexed left atrial volume.ensive subgroup, the prevalence was lowest (2.5% for men
nd 3.2% for women), with no significant difference be-
ween the sexes (p  0.646) (Table 4). In comparison,
ndividuals with hypertension but without obesity presented
ith significantly higher prevalence of LAE (15.2%; p 
.001 for men and 11.0%; p  0.001 for women). Obese
ormotensive individuals also presented with a significantly
ncreased prevalence of LAE (12.2%; p  0.001 for men
nd 13.6%; p  0.001 for women). Comparing the crude
revalences separately for both sexes showed no statistically
ignificant difference between normal-weight hypertensive
atients and obese normotensive individuals. The highest
revalence of LAE was seen in the obese hypertensive
ubgroup (15.7%, p  0.001 for men; 30.5%, p  0.001 for
omen). Of note, the latter values significantly differed
rom all other subgroups (Table 4). In adjusted logistic
egression models (Fig. 2), both hypertension and obesity
ere significant independent predictors of LAE. Obesity
OR: 2.4; 95% confidence interval [CI]: 1.6 to 3.7; p 
.001) was numerically a stronger predictor than hyperten-
ion (OR: 2.2; 95% CI: 1.4 to 3.4; p  0.001).
As estimated by the population-attributable risk, obesity
ccounted for 32.4% (hypertension 30.4%) of LAE observed
t baseline in the entire population. Interestingly, with a
raditional partition value for LAE (LA volume indexed by
Model 2 iLA Model 3 iLA
 p Value  p Value
0.111 0.002 0.135 0.001
0.035 0.284 0.000 0.992
0.215 0.001 0.173 0.001
0.123 0.001 0.064 0.077
— — — —
— — — —
— — — —
0.057 0.080 0.077 0.021
3) during 10 years of follow-up. Regression coefficients () and respective p values for regression
); age, sex, obesity, hypertension, and cardiovascular disease (model 2; R2 0.12); and age, sex,
artition Values for Differentndex ng of Left At ial VolumeTable 3 Partition Values for DifferentIndexing of Left Atrial Volume
Mean SD Mean  2SD Rel Dev
Men
LA (ml) 42.5 10.5 63.5 0.13
LA/BSA (ml/m2) 22.1 5.2 32.5 0.01
LA/height (ml/m) 24.1 5.8 35.7 0.05
Women
LA (ml) 36.3 9.6 55.5
LA/BSA (ml/m2) 21.7 5.5 32.8
LA/height (ml/m) 22.2 5.8 33.7
SA  body surface area; LA  volume of left atrium obtained in apical 4-chamber view; Rel
ev  relative deviation of partition values (PV) men versus women as calculated: (PVmen 
Vwomen)/([PVmen  PVwomen]/2).model
 0.16).
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Risk Factors for Left Atrial Enlargement November 17, 2009:1982–9ody surface area [BSA] 33.0 ml/m2 for both sexes), the
rude prevalence of LAE was lower, especially in the obese
ubgroups (Table 4).
ncidence of LAE. The crude incidence of LAE in the
ntire study sample after 10 years of follow-up was 18.7%
or men and 21.1% for women (p  0.397 between sexes).
n the normal-weight normotensive subgroup, the incidence
as lowest (men 10.9% and women 11.6%; p  0.828). As
ompared with respective male and female normal-weight
ormotensive subgroups, a higher incidence of LAE was
ound in nonobese women with hypertension (30.0%; p 
.001) but not in respective men (14.3%; p  0.496). In
ontrast, compared with the normal-weight normotensive
ubgroups, obese normotensive individuals displayed a sig-
ificantly higher incidence of LAE in both sexes (women
4.8%, p  0.001; men 38.2%, p  0.001). A similar
ncidence of LAE was seen in the obese hypertensive
ubgroup (women 25.0%, p  0.004; men 44.7%, p 
.001). In adjusted logistic regression models (Fig. 3), only
besity was a significant independent predictor of incident
AE (obesity OR: 2.7; 95% CI: 1.8 to 4.1; p  0.001;
ypertension OR: 1.1; 95% CI: 0.7 to 1.7; p  0.564).
elation of LA pressure and volume load to LA size. To
valuate the influence of LA pressure and volume load on LA
ize, linear regression analyses were performed (Table 5). A
ignificant association of LA pressure load (as estimated
y the S/D ratio) with LA size was only found in
ypertensive subgroups. In contrast, a significant association
rude Prevalence of LAETable 4 Crude Prevalence of LAE
Men
n Prevalence OR (95% CI
Total population 582 9.6% (8.2%)* —
Normal weight normotensive 238 2.5% (2.5%)* —
Normal weight hypertensive 112 15.2% (13.4%)* 6.9 (2.6–18.1
Obese normotensive 98 12.2% (10.2%)* 5.4 (2.0–14.8
Obese hypertensive 134 15.7% (12.7%)* 7.2 (2.8–18.3
rude prevalence of LAE based on internal MONICA-Augsburg partition value (men iLA 35.7 ml/
27.8 kg/m2), normal-weight hypertensive (systolic/diastolic blood pressure140/90mmHg or d
ith chi-square tests (vs. normal-weight normotensive individuals). *Crude prevalence using a tradit
ndividuals; men: OR: 1.0 (95% CI: 0.5 to 2.1), p  0.915; women: OR: 3.6 (95% CI: 1.7 to 7.6), p
R: 2.9 (95% CI: 1.3 to 5.9), p  0.006.
BMI  body mass index; BSA  body surface area; CI  confidence interval; iLA  indexed left
Figure 2 Prevalence Odds Ratios for Left Atrial Enlargement
Odds ratios with 95% confidence intervals; results of logistic
regression model, adjusted for age (risk per decade) and sex.etween LA volume load (as estimated by the SV) and LA
ize was found in the obese and normal-weight normotensive
ubgroups.
djusted mean values of iLA. To further delineate the
nfluence of obesity and hypertension on LA volume, we
alculated adjusted mean iLA values (Fig. 4). The iLA in
he normal-weight hypertensive group was significantly
igher than in the normal-weight normotensive group.
besity alone was associated with a significantly stronger
ncrease in LA size than hypertension. The largest LA size
as found in the obese hypertensive subgroup. Additionally,
e evaluated the effect of obesity and hypertension on
hanges in iLA during aging of 10 years (Fig. 5). Except for
he normal-weight normotensive subgroup, there was a
ignificant increase in iLA detectable in all other groups.
he highest increase in iLA was found in the obese
ormotensive and in the obese hypertensive patients.
iscussion
o our knowledge, this is the first evaluation of factors
ffecting LA remodeling during aging over 10 years. Both
ypertension and obesity were identified as independent
redictors of LAE. Besides aging itself, obesity was the
trongest risk factor for incident LAE studied. Further-
ore, our results suggested that LAE in obese and in
ypertensive individuals may be caused by different patho-
hysiologic mechanisms.
Women
p Value n Prevalence OR (95% CI) p Value
— 630 10.0% (7.8%)* — —
— 347 3.2% (2.9%)* — —
0.001 100 11.0% (11.0%)* 3.8 (1.6–9.0) 0.001
0.001 88 13.6% (10.2%)* 4.8 (2.1–11.3) 0.001
0.001† 95 30.5% (20.0%)* 13.4 (6.4–28.2) 0.001†
en iLA 33.7 ml/m) among normal-weight normotensive (men BMI 27.3 kg/m2; women BMI
bese normotensive individuals, and obese hypertensivemen and women. p values were calculated
rtition value for LAE (LA volume indexed by BSA33ml/m2). †Versus normal-weight hypertensive
1; versus obese normotensive individuals; men: OR: 1.3 (95% CI: 0.6 to 2.9), p  0.460; women:
olume; LA  left atrial; LAE  left atrial enlargement; OR  odds ratio.
Figure 3 Incidence Odds Ratios for Left Atrial Enlargement
Odds ratios with 95% confidence intervals; results of logistic
regression model, adjusted for age (risk per decade) and sex.)
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November 17, 2009:1982–9 Risk Factors for Left Atrial Enlargementbesity is the main risk factor for LAE. Several studies
ave identified BMI as an independent predictor of LA size
n adults (22,23). Our data confirmed this strong relation in
large population-based sample. Particularly, we found
trong associations of obesity, arterial hypertension, and age
ith LA size. In linear regression models, the effect of
besity was almost twice the effect of hypertension. We also
ssessed the impact of the concurrence of obesity and
ypertension on LA volume index. After adjustment for age
nd sex, obesity resulted in higher iLA than hypertension.
Wang et al. (24) found obesity to be an important risk
actor for new-onset atrial fibrillation. The increased risk for
trial fibrillation associated with obesity appeared to be
ediated by LA dilation. Interestingly, in their multivariate
egression models, the association between BMI and risk of
trial fibrillation was not significantly influenced by systolic
lood pressure. This is in line with our observations, which
evealed obesity to be the main risk factor for LAE during
ging.
With regard to the increasing prevalence of obesity in
ndustrialized countries, development of effective primary
Figure 4 Adjusted Mean Values for iLA
Adjusted mean values with 95% confidence intervals as estimated with univari-
ate variance analysis, adjusted for age and sex; p values for comparison with
normal-weight normotensive individuals: p  0.016 versus normal-weight
hypertensive patients; #p  0.001 versus normal-weight hypertensive patients;
p  0.001 versus obese normotensive individuals. iLA  indexed left atrial
volume.
elation of Volume and Pressureoad to Indexed L ft Atrial VolumeTable 5 R lation of Volume and PressureLoad to Indexed Left Atrial Volume
S/D Ratio
(Pressure Load)
Stroke Volume
(Volume Load)
 p Value  p Value
Normal weight normotensive 0.005 0.939 0.389 0.001
Normal weight hypertensive 0.351 0.001 0.063 0.361
Obese normotensive 0.136 0.171 0.306 0.002
Obese hypertensive 0.168 0.010 0.292 0.001
egression coefficients () and respective p values for regression models including S/D ratio,
troke volume, and age and sex (data not shown). Data derived from the follow-up investigation.rrevention strategies are essential to avoid premature
ardiovascular remodeling. It remains unclear, however,
o what extent weight maintenance or moderate weight
oss has beneficial effects, resulting in regression of LAE.
vidence in this field is limited. There are only a few
tudies available investigating the effect of substantial
eight loss in morbid obese individuals (25). Whether these
esults can be applied to the general population needs
urther investigation.
Varying methods and partition values exert a prominent
nfluence on the proportion of patients identified as having
AE. Currently the recommended and most frequently
sed parameter for normalization of LA volume measure-
ents is BSA (26). However, because BSA is calculated
sing body height and weight, indexing of LA volume by
SA may lead to an underestimation of LA remodeling,
specially in obese individuals (20,21). Therefore, the best
ethod for normalization of LA volume measurements is
till being debated. For example, normalization of LV mass
o the power of its allometric or growth relation with height
height2.7) enhanced the ability to detect LV hypertrophy
elated to obesity (27). Consequently, we suggest a body
eight–independent indexing of LA volume. As demon-
trated in this paper, indexing of LA volume by body height
nhanced the ability to detect LAE related to obesity.
ypertension and LAE. A direct relation between systolic
lood pressure and LA size has been demonstrated in
everal population-based studies (7,28,29). Furthermore, in
atients with essential hypertension, LAE is a common
chocardiographic finding with a significant relation to LV
ass (4). In hypertensive individuals, cardiac adaptations
ay be due to pressure overload of the LA that is primarily
Figure 5 Adjusted Mean Values for Absolute Changes of iLA
Adjusted mean values with 95% confidence intervals as estimated with univari-
ate variance analysis, adjusted for age, sex, and the baseline measurement of
left atrial volume; p values for comparison with normal-weight normotensive
individuals: p  0.042 versus normal-weight hypertensive patients; #p 
0.012 versus normal-weight hypertensive patients; p  0.607 versus obese
normotensive individuals. iLA  indexed left atrial volume.elated to impaired filling secondary to concentric hypertro-
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Risk Factors for Left Atrial Enlargement November 17, 2009:1982–9hy (5,30). Impaired LV filling may lead to an increased LA
ressure, ultimately resulting in LAE.
By contrast, the mechanisms by which obesity may
romote LAE are more complex (30). Obese patients may
ndergo LA dilation resulting from hemodynamic alter-
tions like increased intravascular volume and increased
ardiac output (3,30). Subsequently, these alterations may
ead to LA volume overload (31).
Within this study a significant association of LA size to
ndirectly estimated LA pressure was only found in individ-
als presenting with hypertension. By contrast, in obese
ndividuals, a significant relation between LA size and LA
olume load was detectable. These findings strengthen the
otion that LAE in obese and in hypertensive individuals
ay be caused by different pathophysiologic mechanisms.
urthermore, our data suggest that LA pressure load in
ypertensive individuals resulted in an increase in LA size
arly after occurrence of the disease (i.e., the association
ith prevalent LAE was relatively strong). However, further
AE during follow-up was observed to a much lesser
xtent, resulting in low incidence of LA dilation in hyper-
ensive individuals. In contrast, chronic LA volume load
ithin the obese may result in a continuous enlargement of
he left atrium as indicated by significant associations with
oth prevalent and incident LAE. Comparing the relation
f obesity and hypertension with LAE, this observation may
artly explain the stronger role of obesity.
he left atrium: underestimated prognostic factor? The
urrent study contributes to the mounting evidence that
besity (22,23) and hypertension (9,20) lead to LAE. As a
esult, the incidence of atrial fibrillation, with its subsequent
isks of stroke and heart failure, rises in obese (24,32) and in
ypertensive individuals (32,33). Because of the higher
revalence of hypertension in the general population, more
ases of atrial fibrillation are related to this condition than to
ny other cardiovascular risk factor (34). However, with
egard to the increasing prevalence of severe obesity in
eveloped countries, its importance in the development of
trial fibrillation will increase and may replace arterial
ypertension as the main risk factor.
tudy limitations. We report an association in a rather
omplex biologic system with multiple interactions. Thus, it is
ifficult to establish causal relationships using the present
ross-sectional study design. In this study, definition of diabe-
es was limited (e.g., there was no fasting glucose level
vailable) and the number of diabetic patients was relatively
mall. As a result, the relation of diabetes and LA size still
emains unclear and needs further investigation. Moreover, we
ad to rely on 2 single measurements to represent a period of
0 years. Thus, fluctuations of blood pressure, glucose levels, or
ther risk factors or the effects of intermittent medications were
ot included in our analyses. Finally, the prevalence of atrial
brillation within this cohort was low (0.8%). It was therefore
ot possible to draw any firm conclusion about the determi-
ants of atrial fibrillation.onclusions
oth obesity and hypertension were found to be indepen-
ent risk factors for LAE and are probably acting through
ifferent pathophysiologic mechanisms. However, in the
eneral population, obesity appears to be the most impor-
ant risk factor. With regard to the increasing prevalence of
xcess obesity in developed countries, early interventions,
specially in young obese individuals, are essential for the
revention of premature onset of cardiac remodeling.
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